BBA
Baker Bros. Advisors Portfolio holdings
AUM
$10.3B
This Quarter Return
+33.77%
1 Year Return
+63.34%
3 Year Return
+231.6%
5 Year Return
+293.68%
10 Year Return
+1,612.7%
AUM
$15.6B
AUM Growth
+$15.6B
(+28%)
Cap. Flow
+$12.7M
Cap. Flow
% of AUM
0.08%
Top 10 Holdings %
Top 10 Hldgs %
85.51%
Holding
100
New
7
Increased
16
Reduced
6
Closed
4
Top Buys
1 |
Ascendis Pharma
ASND
|
$65.1M |
2 |
MYOK
MyoKardia, Inc. Common Stock
MYOK
|
$36.4M |
3 |
Neurocrine Biosciences
NBIX
|
$32.4M |
4 |
BOLD
Audentes Therapeutics, Inc
BOLD
|
$31.4M |
5 |
Axsome Therapeutics
AXSM
|
$17.1M |
Top Sells
1 |
GHDX
Genomic Health, Inc.
GHDX
|
$108M |
2 |
ONCE
Spark Therapeutics, Inc. Common Stock
ONCE
|
$72M |
3 |
ARRY
Array Biopharma Inc
ARRY
|
$29.2M |
4 |
Solid Biosciences
SLDB
|
$15.8M |
5 |
Novavax
NVAX
|
$8.68M |
Sector Composition
1 | Healthcare | 93.53% |